Today, Aignostics announced research results for Atlas 2, an updated version of its pathology foundation model. Built in collaboration with Mayo Clinic, LMU Munich and Charité – Universitätsmedizin ...
Modella AI, a leader in artificial intelligence for life sciences, today announced that it has been acquired by AstraZeneca, ...
SAN FRANCISCO, Jan 13 () - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug ...
The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...
The collaboration enables seamless integration of Owkin's advanced pathology analysis capabilities into Claude's AI platform, ...
CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034Precision Pathology Laboratory Services meets gold standard for excellence across all ...
According to MarketsandMarkets™, the Al in Clinical Workflow Market is projected to grow from about USD 2.78 billion in 2025 ...
Postmortem Pathology today announced a significant expansion of its private autopsy services In St. Louis, Missouri for ...
TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either Dato-DXd (6.0 mg/kg intravenously every 3 weeks) or docetaxel (75 mg/m² ...
Flow Space on MSN
Cervical Cancer May Be Eliminated By 2030
The largest barriers to elimination are no longer scientific. The science and tech are finally here—women just need to catch ...
Biopharmaceutical artificial intelligence startup Owkin Inc. said today it’s making a series of autonomous agents focused on ...
Alterity Therapeutics is a late clinical-stage biotech company focused on developing treatments for serious neurodegenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback